Legal & General Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.23K Buy
+310
New +$7.23K ﹤0.01% 3353
2024
Q2
Sell
-120
Closed -$3.95K 3527
2024
Q1
$3.95K Hold
120
﹤0.01% 3313
2023
Q4
$3.22K Hold
120
﹤0.01% 3348
2023
Q3
$7.28K Hold
120
﹤0.01% 3321
2023
Q2
$12.3K Sell
120
-2,529
-95% -$259K ﹤0.01% 3277
2023
Q1
$468K Sell
2,649
-340
-11% -$60.1K ﹤0.01% 2326
2022
Q4
$1.16M Buy
2,989
+63
+2% +$24.4K ﹤0.01% 2111
2022
Q3
$986K Buy
2,926
+182
+7% +$61.3K ﹤0.01% 2151
2022
Q2
$902K Sell
2,744
-40
-1% -$13.1K ﹤0.01% 2196
2022
Q1
$1.22M Sell
2,784
-25
-0.9% -$10.9K ﹤0.01% 2172
2021
Q4
$1.23M Buy
2,809
+102
+4% +$44.7K ﹤0.01% 2190
2021
Q3
$1.51M Buy
2,707
+177
+7% +$98.5K ﹤0.01% 2146
2021
Q2
$1.3M Buy
2,530
+2,321
+1,111% +$1.19M ﹤0.01% 2137
2021
Q1
$163K Hold
209
﹤0.01% 2494
2020
Q4
$113K Hold
209
﹤0.01% 2553
2020
Q3
$96K Sell
209
-51
-20% -$23.4K ﹤0.01% 2504
2020
Q2
$160K Buy
260
+15
+6% +$9.23K ﹤0.01% 2407
2020
Q1
$116K Sell
245
-47
-16% -$22.3K ﹤0.01% 2373
2019
Q4
$170K Buy
292
+36
+14% +$21K ﹤0.01% 2434
2019
Q3
$168K Buy
256
+26
+11% +$17.1K ﹤0.01% 2385
2019
Q2
$178K Buy
230
+67
+41% +$51.9K ﹤0.01% 2376
2019
Q1
$115K Buy
163
+9
+6% +$6.35K ﹤0.01% 2451
2018
Q4
$72K Hold
154
﹤0.01% 2562
2018
Q3
$132K Buy
154
+41
+36% +$35.1K ﹤0.01% 2433
2018
Q2
$78K Sell
113
-27
-19% -$18.6K ﹤0.01% 2571
2018
Q1
$62K Sell
140
-56
-29% -$24.8K ﹤0.01% 2650
2017
Q4
$88K Sell
196
-33
-14% -$14.8K ﹤0.01% 2648
2017
Q3
$112K Buy
229
+30
+15% +$14.7K ﹤0.01% 2587
2017
Q2
$118K Buy
199
+19
+11% +$11.3K ﹤0.01% 2518
2017
Q1
$117K Sell
180
-7
-4% -$4.55K ﹤0.01% 2463
2016
Q4
$63K Buy
187
+84
+82% +$28.3K ﹤0.01% 2809
2016
Q3
$30K Hold
103
﹤0.01% 2738
2016
Q2
$18K Hold
103
﹤0.01% 2857
2016
Q1
$23K Hold
103
﹤0.01% 2651
2015
Q4
$59K Buy
+103
New +$59K ﹤0.01% 2371